Cancer Research as a Care Option in Rural Montana—The State has Come A Long Way
The clinical research as a care option has come a long way in the large, massive, primarily rural State of […]
Racial Disparities in Cancer Enter the Spotlight—Again
Blacks “have the highest death rate and shortest survival of any racial/ethnic group in the U.S. for most cancers,” according […]
ACCC Joins ASCO in Efforts to Improve Minority Representation in Cancer Clinical Trials
The Association of Community Cancer Centers (ACCC) has partnered with the American Society of Clinical Oncology (ASCO) in a collaborative […]
More Intelligent Diagnosis & Matching Cancer Patients with Trials: Does the Precipio & TrialJectory Combo Overcome the Barriers?
New York area-based TrialJectory, an AI-powered technology platform venture supplying clinical trial-matching service supporting the clinical trial search, enrollment and engagement […]
Clinical Trials May Be Next Best Option with Hidradenitis Supperativa
A 50% increase in clinical trials between 2017 and 2019, devoted to reducing symptoms of hidradenitis supperativa, may be a […]
Kaiser Permanente Participating in AbbVie-Sponsored International Clinical Trial Targeting Ovarian Cancer with PARP Inhibitor Called Veliparib
Kaiser Permanente Research radio recently interviewed Dr. Michael A Bookman, an oncologist and investigator with Kaiser, discussing his participation in […]
UW-Madison Professor and Team To Lead The Nation’s Coordinating Center for the National Cancer Institute Cancer Prevention Clinical Trials Network
KyungMann Kim, a professor of biostatistics and medical informatics at the UW School of Medicine and Public Health, has received […]
Time to Infuse Patient Navigation into Cancer Clinical Trials
TrialSite News reported in its African American clinical trial participation survey that best practices we have learned from experience on […]
UCSF Does First Patient in Triple Combo Clinical Trial for Squamous Cell Head & Neck Cancer
TRIFECTA is an investigator-initiated, single-arm, open-label, clinical trial in which 35 evaluable Squamous Cell Head and Neck Cancer (SCCHN) patients […]
Interim Data from Phase I/II CLASSICAL-Lung Trial Shows Signs of Efficacy in Advanced NSCLC
Vaccinex presented at 2019 Annual Meeting of the American Association for Cancer Research, demonstrating the combination of pepinemab with avelumab […]
